As of November 2024, Biomark Diagnostics has a market cap of $16.69M. This makes Biomark Diagnostics the world's 30871th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $19.03M | 11.76% |
2023 | $17.02M | 15.91% |
2022 | $14.69M | -18.52% |
2021 | $18.02M | 80.00% |
2020 | $10.01M | -34.78% |
2019 | $15.35M | 411.11% |
2018 | $3.00M | -52.63% |
2017 | $6.34M | -20.83% |
2016 | $8.01M | 0.00% |
2015 | $8.01M | -74.47% |
2014 | $31.38M | - |